Contact Us

Sarah Scruggs
(202) 249-6525

WASHINGTON (February 1, 2018) – Cal Dooley, President and CEO of the American Chemistry Council (ACC) issued the following statement in response to the U.S. House Science, Space, & Technology Committee’s (SST) decision to hold a full committee hearing examining the International Agency for Research on Cancer’s (IARC) Monographs Program and glyphosate review.

“The lack of transparency, frequent conflicts of interest, questionable carcinogen classifications and misleading communications associated with IARC’s Monographs Program have been glossed over for long enough. I applaud Chairman Smith and the House Science Committee for examining IARC’s controversial methods and questionable classifications, including reports that the Agency manipulated its glyphosate monograph to reach a predetermined, unjustified conclusion.

“IARC’s persistent disregard for scientific evidence and objectivity raises questions about the validity of all IARC Monographs and underscores the need to fundamentally reform the Monographs Program. It is both unfortunate and alarming that IARC Director Christopher Wild refused repeated requests from the Committee to provide witnesses to testify at the hearing. IARC’s absence and refusal to cooperate reinforces concerns about the Agency’s commitment to transparency and accountability, and raises questions about its interest in producing cancer hazard assessments, which can have a meaningful impact on public health.”


News & Resources

View our resource center to find press releases, testimonies, infographics and more.